039200.KQ
Oscotec Inc.
KOE · Healthcare · Drug Manufacturers - General · KR
KRW 36,500.00
−0.41%Year over year
Reported trailing growth
- Revenue
- +232.6%
- EBITDA
- +415.2%
- EBIT
- +2354.5%
- EPS
- +2112.8%
- Free cash flow
- —
- Operating cash flow
- +6154.2%
Forward estimates
Based on analyst estimates
- Revenue
- -97.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +170.2%
- EBITDA
- +2874.7%
- EBIT
- +2005.0%
- Net income
- +5895.6%
- EPS
- +5870.2%
- Free cash flow
- +128.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026